RVP · Retractable Technologies Inc · Executive Compensation

$0.56 +0.00 (+0.09%) At close · Nov 12

Market Cap

$16.62M

29.94M

Volume · Nov 12 17.86K Avg daily vol (3M) 32.86K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$1,211,545	—	—	—	—	$10,500	$1,222,045
Michele M. Larios	Vice President, General Counsel	$400,000	—	—	—	—	$10,500	$410,500
John W. Fort III	Vice President, CFO (principal financial officer, principal accounting officer)	$300,000	—	—	—	—	$9,992	$309,992
Kevin McGlinchey	Vice President of Domestic Sales Development	$275,000	$500	—	—	—	$16,953	$292,453
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$500	—	—	—	$4,973	$203,879

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$1,178,295	—	—	—	—	$10,350	$1,188,645
Michele M. Larios	Vice President, General Counsel	$400,000	—	—	—	—	$10,350	$410,350
John W. Fort III	Vice President, CFO (principal financial officer, principal accounting officer)	$300,000	—	—	—	—	$9,000	$309,000
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$500	—	—	—	$4,973	$203,879
Lawrence G. Salerno	Director of Operations	$188,000	$500	—	—	—	$5,655	$194,155

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$1,139,550	—	—	—	—	$9,900	$1,149,450
Michele M. Larios	Vice President, General Counsel	$400,000	—	—	—	—	$5,457	$405,457
John W. Fort III	Vice President, CFO (principal financial officer, principal accounting officer)	$300,000	—	—	—	—	$9,346	$309,346
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$500	—	—	—	$12,050	$210,956
Lawrence G. Salerno	Director of Operations	$188,000	$500	—	—	—	$7,587	$196,087

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$1,068,654	—	—	—	—	$9,150	$1,077,804
Michele M. Larios	Vice President, General Counsel	$400,000	—	—	—	—	$5,538	$405,538
John W. Fort III	Vice President, CFO (principal financial officer, principal accounting officer)	$300,000	—	—	—	—	$2,769	$302,769
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$327	—	—	—	$4,960	$203,693
Lawrence G. Salerno	Director of Operations	$188,000	$327	—	—	—	$5,423	$193,750

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$1,000,000	$300,000	—	$10,212,000	—	$5,800	$11,517,800
Michele M. Larios	Vice President, General Counsel	$400,000	$100,000	—	$2,552,500	—	$1,346	$3,053,846
John W. Fort III	Vice President, CFO (principal financial officer, principal accounting officer)	$300,000	$100,000	—	$1,021,000	—	$5,538	$1,426,538
Kathryn M. Duesman	Vice President of Clinical Affairs	$192,156	$124,767	—	—	—	$3,841	$320,764
Lawrence G. Salerno	Director of Operations	$179,667	$106,775	—	—	—	$3,511	$289,953

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$511,016	—	—	—	—	$5,700	$516,716
Michele M. Larios	Vice President, General Counsel	$350,000	—	—	—	—	$1,015	$351,015
Clinical Affairs	—	$180,912	$100,000	—	—	—	$3,608	$284,520
Kathryn M. Duesman	Vice President of Clinical Affairs	$180,912	$100,000	—	—	—	$3,608	$284,520
Lawrence G. Salerno	Director of Operations	$165,333	$100,000	—	—	—	$5,305	$270,638
John W. Fort III	Vice President, CFO (principal financial officer, principal accounting officer)	$200,000	—	—	—	—	$4,000	$204,000
Russell B. Kuhlman	Vice President, Sales Development	$153,649	—	—	—	—	$3,062	$156,711

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$499,526	—	—	—	—	$5,600	$505,126
Michele M. Larios	Vice President, General Counsel	$350,000	—	—	—	—	$2,962	$352,962
John W. Fort III	Vice President, CFO (principal financial officer, principal accounting officer)	$200,000	—	—	—	—	$923	$200,923
Global Health	—	$174,999	—	—	—	—	$3,493	$178,492
Kathryn M. Duesman	Vice President of Clinical Affairs	$174,999	—	—	—	—	$3,493	$178,492
Lawrence G. Salerno	Director of Operations	$148,722	—	—	—	—	$2,992	$151,714
Russell B. Kuhlman	Vice President, Sales Development	$148,728	—	—	—	—	$2,968	$151,696
Douglas W. Cowan	Former Vice President and CFO (former principal financial officer and principal accounting officer)	$105,879	—	—	—	—	$2,118	$107,997

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	President and CEO (principal executive officer)	$490,247	—	—	—	—	$5,500	$495,747
Michele M. Larios	Vice President, General Counsel	$350,000	—	—	—	—	$5,500	$355,500
Douglas W. Cowan	Former Vice President and CFO (former principal financial officer and principal accounting officer)	$290,000	—	—	—	—	$5,500	$295,500
Kathryn M. Duesman	Vice President of	$174,999	—	—	—	—	$3,359	$178,358
Russell B. Kuhlman	Vice President, Sales Development	$148,728	—	—	—	—	$2,857	$151,585

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michele M. Larios	Vice President, General Counsel	$350,000	$250,000	—	—	—	$5,400	$605,400
Douglas W. Cowan	Former Vice President and CFO (former principal financial officer and principal accounting officer)	$290,000	$250,000	—	—	—	$4,908	$544,908
Thomas J. Shaw	President and CEO (principal executive officer)	$479,694	—	—	—	—	$5,400	$485,094
Kathryn M. Duesman	Executive Director,	$175,012	—	—	—	—	$3,493	$178,505
Russell B. Kuhlman	Vice President, Sales Development	$148,741	—	—	—	—	$2,968	$151,709

Leadership

Key facts CIK 946563 CUSIP 76129W105 13F (30d) 18 filings 15 filers Visit website Investor relations